PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsresidual neoplasm
MeSH D018365 - residual neoplasm
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009385:Neoplastic processes
$
Success rate
D018365: 
Residual neoplasm
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
95%
18/19
Phase 2
0%
0/38
Phase 3
0%
0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use